This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Cano Health 과거 수익 실적

과거 기준 확인 0/6

Cano Health의 수입은 연평균 -83.5%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 5.6%의 비율로 증가했습니다. 매출은 연평균 33.4%의 비율로 증가해 왔습니다.

주요 정보

-83.5%

수익 성장률

-88.2%

EPS 성장률

Healthcare 산업 성장	8.5%
매출 성장률	33.4%
자기자본 수익률	n/a
순이익	-33.2%
최근 수익 업데이트	31 Mar 2024

최근 과거 실적 업데이트

Recent updates

Cano Health: Common Shareholders Likely To Be Wiped Out In Bankruptcy

Feb 06

Cano Health: Bankruptcy Likely After Dismal Q2 Results And Debt Covenant Violations

Aug 11

Cano Health: CEO Departure Could Be Constructive, New Skipper More So

Jun 20

Cano Health: Key Shareholder Meeting Looms, Stock Undervalued But Volatile

Jun 09

Analyst Estimates: Here's What Brokers Think Of Cano Health, Inc. (NYSE:CANO) After Its First-Quarter Report

May 12

수익 및 비용 분석

Cano Health 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

OTCPK:CANO.Q 수익, 비용 및 수입 (USD Millions )
날짜	수익	수익	G+A 비용
31 Mar 24	2,955	-982	350
31 Dec 23	3,138	-594	357
30 Sep 23	3,102	-578	380
30 Jun 23	2,979	-372	410
31 Mar 23	2,901	-236	422
31 Dec 22	2,739	-207	422
30 Sep 22	2,551	-58	408
30 Jun 22	2,385	-27	373
31 Mar 22	2,039	-17	314
31 Dec 21	1,609	-18	252
30 Sep 21	1,379	-65	193
30 Jun 21	1,143	-53	143
31 Mar 21	971	-69	118
31 Dec 20	832	-71	104
30 Sep 20	677	-24	90
31 Dec 19	361	-20	59
31 Dec 18	231	-9	35

양질의 수익: CANO.Q 은(는) 현재 수익성이 없습니다.

이익 마진 증가: CANO.Q 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: CANO.Q 은(는) 수익성이 없으며 지난 5년 동안 연간 83.5% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 CANO.Q 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: CANO.Q 은(는) 수익성이 없어 지난 해 수익 성장을 Healthcare 업계( 15.1% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: CANO.Q 의 부채가 자산을 초과하므로 자기자본수익률을 계산하기 어렵습니다.

This company listing is no longer active

Cano Health 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

Cano Health, Inc. Reports Unaudited Consolidated Goodwill Impairment Loss for the Third Quarter Ended September 30, 2023

Cano Health, Inc. Reports Unaudited Consolidated Goodwill Impairment Loss for the Third Quarter Ended September 30, 2023

Third quarter 2023 earnings released: US$91.87 loss per share (vs US$23.34 loss in 3Q 2022)

Cano Health, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Cano Health, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Recent updates

First Motion for Exclusivity Period Extension Approved For Cano Health, Inc.

Fourth Amended Disclosure Statement Approved for Cano Health, Inc.

Fourth Amended Reorganization Joint Plan and Disclosure Statement Filed by Cano Health, Inc.

Third Amended Reorganization Joint Plan and Disclosure Statement Filed by Cano Health, Inc.

Second Amended Reorganization Plan and Disclosure Statement Filed by Cano Health, Inc.

First Amended Joint Reorganization and Disclosure Statement Plan Filed by Cano Health, Inc.

Motion for De Minimis Asset Sale Approved for Cano Health, Inc.

Cano Health, Inc. announced delayed annual 10-K filing

Interim DIP Financing Approved for Cano Health, Inc.

Motion for Joint Administration Filed by Cano Health, Inc.

NYSE to Commence Delisting Proceedings Against Cano Health

Cano Health: Common Shareholders Likely To Be Wiped Out In Bankruptcy

Cano Health, Inc. Filed for Bankruptcy

Cano Health Announces Appointment of Two New Independent Directors

Cano Health, Inc. announced delayed 10-Q filing

Cano Health, Inc. Reports Unaudited Consolidated Goodwill Impairment Loss for the Third Quarter Ended September 30, 2023

Cano Health, Inc. Reports Unaudited Consolidated Goodwill Impairment Loss for the Third Quarter Ended September 30, 2023

Third quarter 2023 earnings released: US$91.87 loss per share (vs US$23.34 loss in 3Q 2022)

High number of new and inexperienced directors

Cano Health Provides Nasdaq Compliance Update

Cano Health, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Cano Health, Inc. Announces the Resignation of Mark Novell as Chief Accounting Officer

Cano Health Receives NYSE Notification Letter; Plans to Regain Compliance with Listing Rules

Cano Health, Inc. Appoints Mark Kent as Chief Executive Officer

Cano Health, Inc. announced delayed 10-Q filing

Cano Health: Bankruptcy Likely After Dismal Q2 Results And Debt Covenant Violations

Price target decreased by 7.4% to US$2.67

Cano Health, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Cano Health, Inc. Announces Board Changes

Chief Clinical Officer recently sold US$709k worth of stock

Chief Clinical Officer notifies of intention to sell stock

Elliot Cooperstone Issues a Response to Cano Health’s Post-Market Announcement

Cano Health: CEO Departure Could Be Constructive, New Skipper More So

New minor risk - Insider selling

Cano Health, Inc. Announces Chief Executive Officer Changes

Chief Clinical Officer recently sold US$1.2m worth of stock

Cano Health, Inc. Announces Announces Chief Executive Officer Changes

Chief Clinical Officer notifies of intention to sell stock

Elliot Cooperstone Posts Materials to his Website

Cano Health: Key Shareholder Meeting Looms, Stock Undervalued But Volatile

Cano Health, Inc. Appoints Frederick Green as Interim Chief Legal Officer

Cano Health, Inc., Annual General Meeting, Jun 15, 2023

Consensus estimates of losses per share improve by 29%

Elliot Cooperstone Sends a Letter to the Shareholders of Cano Health, Inc

Analyst Estimates: Here's What Brokers Think Of Cano Health, Inc. (NYSE:CANO) After Its First-Quarter Report

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기